2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders

Novel pyrimidine derivatives of formula (I) and their use for the manufacture of a medicament for the treatment or prevention of a disease which responds to inhibition of FAK and/or ALK and/or ZAP-70 and/or IGF-IR. in which: n' is selected from 1,2 and 3; R' 1 is selected from phenyl, pyri...

Full description

Saved in:
Bibliographic Details
Main Authors KARANEWSKY, DONALD, ZHANG, QIONG, WAN, YONGQIN, MIYAKE, TAKAHIRO, JIANG, JIQING, KAWAHARA, EIJI, KANAZAWA, TAKANORI, DING, QIANG, GARCIA-ECHEVERRIA, CARLOS, GRAY, NATHANAEL, SCHIANDER, CHOPIUK, GREG, OHMORI, OSAMU, STEENSMA, RUO, MASUYA, KEIICHI, MATSUURA, NAOKO, UMEMURA, ICHIRO
Format Patent
LanguageEnglish
French
German
Published 29.05.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Novel pyrimidine derivatives of formula (I) and their use for the manufacture of a medicament for the treatment or prevention of a disease which responds to inhibition of FAK and/or ALK and/or ZAP-70 and/or IGF-IR. in which: n' is selected from 1,2 and 3; R' 1 is selected from phenyl, pyridinyl, pyrazolyl and pyrimidinyl; and R' 2 and R' 3 are as described herein.
Bibliography:Application Number: EP20100010291